All Updates

All Updates

icon
Filter
Funding
Triomics raises USD 15 million in venture funding
Clinical Trial Technology
May 10, 2024
This week:
Funding
Lhyfe receives EUR 11 million grant from Klimatklivet for green hydrogen project in Sweden
Hydrogen Economy
Yesterday
Product updates
XRAI Glass launches AR One glasses at USD 1449 for hearing-impaired individuals
Extended Reality
Yesterday
Funding
VR therapy platform CUREosity raises EUR 3.8 million in funding to expand market presence
Extended Reality
Yesterday
Last week:
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Decentralized Finance (DeFi)
Jun 22, 2024
Product updates
Coinbase updates mobile wallet to add decentralized app browser
Web3 Ecosystem
Jun 22, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Data Infrastructure & Analytics
Jun 21, 2024
M&A
OpenAI acquires Rockset to power retrieval infrastructure
Foundation Models
Jun 21, 2024
Partnerships
Product updates
Anthropic releases Claude 3.5 Sonnet, the first model in the 3.5 series
Foundation Models
Jun 21, 2024
Funding
Paramount Planet Product raises USD 1 million in federal grant funding to support commercialization
Bio-based Materials
Jun 21, 2024
Regulation/policy
Apple delays launch of Apple Intelligence features in EU citing regulatory concerns
Generative AI Applications
Jun 21, 2024
Clinical Trial Technology

Clinical Trial Technology

May 10, 2024

Triomics raises USD 15 million in venture funding

Funding

  • Triomics, a provider of a patient recruitment platform for oncology-related clinical trials, has raised USD 15 million in a venture funding round, which saw participation from investors including Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator.

  • The raised funds will be used to develop the company’s platform and roll it out to new customers. The company notes that as of May 2024, its solution is being used by six cancer centers and hospitals, a number it plans to double by the end of the year.

  • Triomics has developed an AI-based platform to enhance cancer care by helping trial operators secure patients for clinical trials, prevent delays in patient care, eliminate backlogs and inefficiencies, and eliminate provider burnout. The company’s work revolves around developing an AI model, "OncoLLM," trained specifically to analyze unstructured oncology data, greatly reducing time wasted on manual data analysis while improving accuracy in patient-trial matching.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.